Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study
Archives of Orthopaedic and Trauma Surgery · 03.07.2026 · 146 (1)
DOI: 10.1007/s00402-026-06401-5 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, online erschienen am 03.07.2026. Verfasst von Lukas Böck und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, University Hospital Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Osteoporosis, Femoral Fractures, Guideline Adherence, Osteoporotic Fractures. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.
Abstract (Originalsprache)
Introduction
Hip fractures are a major complication of osteoporosis and are associated with high morbidity, mortality, and costs. Despite clear guideline recommendations, pharmacological osteoporosis treatment remains underutilized. In addition, medications that increase fall and fracture risk further contribute to fracture occurrence. The aim of this study was to assess guideline concordance of osteoporosis therapy and to quantify the prevalence of medications associated with increased fall and fracture risk prior to the fracture in patients admitted with femoral fractures. Materials and methods In this prospective observational study, 145 patients aged ≥ 55 years admitted with femoral neck, per- and subtrochanteric, femoral shaft and distal femur fractures to a tertiary academic trauma center between April and June 2025 were included. Pre-admission medication was assessed using structured medication reconciliation. Guideline concordance of pre-fracture osteoporosis therapy was evaluated according to the current Austrian osteoporosis guideline (Dimai et al., 2024). Fall-risk-increasing drugs (FRIDs) were identified using the STOPPFall criteria, and fracture-associated medications were recorded based on Austrian osteoporosis guideline-defined drug classes.
Results
Among 145 included patients (mean age 80.4 years; 71% female), 117 (81%) met criteria for pharmacological osteoporosis treatment prior to the fracture, defined by a preexisting osteoporosis diagnosis or a 10-year fracture risk above the treatment intervention threshold using the FRAX ® calculator. Only 9 (7.7%) of these patients were treated in accordance with guideline recommendations. A treatment gap was observed in 78.6% of therapy-eligible patients. At least one FRID was prescribed in 70% of patients, and 57% received at least one medication associated with increased fracture risk.
Conclusions
Patients presenting with femoral fractures demonstrate a substantial gap in guideline-concordant osteoporosis therapy and a high prevalence of medications associated with increased fall and fracture risk. These findings highlight important opportunities for systematic primary and secondary fracture prevention and structured medication review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hospital Pharmacy, University Hospital Vienna, Vienna, Austria.
- Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, Vienna, Austria.
- Department of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria.
- Department of Hospital Pharmacy, Hanusch Hospital, Vienna, Austria.
- Department of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria. anna.antoni@meduniwien.ac.at.
Förderung
- Medical University of Vienna
Zitieren
APA
Böck, L., Kerschan-Schindl, K., Frossard, M., Hajdu, S., Crevenna, R., Anditsch, M., Stemer, G., & Antoni, A. (2026). Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study. Archives of Orthopaedic and Trauma Surgery, 146(1). https://doi.org/10.1007/s00402-026-06401-5
Vancouver
Böck L, Kerschan-Schindl K, Frossard M, Hajdu S, Crevenna R, Anditsch M, et al. Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study. Archives of Orthopaedic and Trauma Surgery. 2026;146(1). doi:10.1007/s00402-026-06401-5
BibTeX
@article{Bck2026,
author = {Böck, Lukas and Kerschan-Schindl, Katharina and Frossard, Martin and Hajdu, Stefan and Crevenna, Richard and Anditsch, Martina and Stemer, Gunar and Antoni, Anna},
title = {Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study},
journal = {Archives of Orthopaedic and Trauma Surgery},
year = {2026},
volume = {146},
number = {1},
doi = {10.1007/s00402-026-06401-5}
}
EUVIMED